Speaker Profile
Ph.D., Director of BD, Therna Biosciences
Biography
Broad experience working in Pharma and Biotech both as a team lead and in Strategy and BD. Amir previously lead discovery teams at two Flagship Pioneering companies Repertoire Immune Medicine and Sail Therapeutics. He has also held positions at Ceptur Therapeutics leading their corporate development efforts as well as working to build Ginkgo Bioworks first product in Antibodies. He recently joined Therna Biosciences to lead their BD efforts around partnering for AIML powered RNA Medicine.
Talk
RNA Design by Intelligent Design.
Using a biology-guided, AI-powered platform, Therna is pioneering programmable RNA therapeutics. Thernas technology is engineered to enhance translation, durability, and precise tissue targeting, which unlocks new levels of safety and efficacy in RNA medicines.
AI for Emerging Therapeutics Showcase:
Therna Biosciences
AI/ML Powered RNA Medicines Therapeutics Company.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2025AI for Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies to explore the transformative role of artificial intelligence in accelerating the discovery, development, and optimization of novel therapeutic modalities. From predictive algorithms for drug efficacy to real-time analysis in clinical trials, AI is revolutionizing the way we approach emerging therapies, including RNA-based treatments, gene editing, and personalized medicine. Industry leaders and experts will discuss AI-driven advancements, collaborative frameworks, and the challenges of integrating cutting-edge technologies into therapeutic innovation. Join us for an in-depth look at how AI is shaping the future of breakthrough therapeutics.
